Check out your Company Bowl for anonymous work chats.
Verily Health began as a moonshot at Google X, The Moonshot Factory in 2015 with the mission to make the world's health data useful. Our CEO Stephen Gillett sat down with Astro Teller on The Moonshot Podcast to discuss our vision for continuing that mission to bring the promise of precision healthcare to everyone, every day. Watch the interview to learn more about Verily’s vision, Verily’s strengths as both a health tech and care company, and the similarities between the future of healthcare and self-driving cars.
The Moonshot Podcast with Verily Health CEO Stephen Gillett
Stephen Gillett, CEO of Verily Health, recently sat down with Investment Reports to discuss how the future of healthcare will be shaped by making data truly usable for AI. He speaks to how we’ve sharpened our focus around this central idea, building our precision health platform, Pre, with the capabilities needed to organize, structure, and apply healthcare data across research, care delivery, and public health. Across this work, we hold the core belief that healthcare transformation requires more than technology alone. It depends on the integration of clinical, regulatory, quality, and ethical expertise alongside advanced AI. We’re excited to continue building toward a more predictive, personalized, and accessible healthcare system.
Stephen Gillet, Verily
Most predictive health models only use EHR data. Our partnership with NVIDIA created Forecast 1.0, a multimodal foundation model that integrates genomics and EHR data to accelerate precision medicine research. The result: A 15.5% relative increase in T2D prediction performance and a 3x increase in model pre-training efficiency using NVIDIA's AI stack in Verily Workbench. 📄 Download the whitepaper.
Whitepaper
The era of generic chatbots is over — Verily Health is setting the beginning of a new standard in AI-enabled care with Violet, our AI health companion. Our clinical approach highlights the critical difference between a "medical chatbot" and a clinical-grade AI system. Our multi-agent architecture for symptom urgency assessment is designed for safety and precision. Here is what defines our clinical-grade AI system: ▶️ Predictable, structured outputs: Every assessment follows a strict schema, including a clear tailored education and agentic reasoning. ▶️ Ensemble reasoning: We run parallel assessments with diverse reasoning styles to reach a conservative, safety-biased consensus. ▶️ Safety by design: Multi-stage emergency detection immediately overrides the workflow for high-acuity scenarios.
Is your AI fit for healthcare? | Verily | Precision Health Company
Announced today at the AWS Life Sciences Symposium! Verily Workbench, our scalable trusted research environment (TRE) for biomedical data analysis and AI/ML development, is now generally available for organizations using Amazon Web Services (AWS). Workbench enables researchers to co-analyze data where it lives, accelerating discovery through integrated AI tools with built-in healthcare compliance. Key benefits of Workbench on AWS: • Secure and compliant TRE built for biomedical data • Scalable analysis with enterprise integration • Zero cloud cost markup • NVIDIA AI stack • Multicloud integration • Free standard tier accounts and data ecosystem "Verily Workbench on AWS provides the enterprise-grade TRE that will empower even more researchers to accelerate data analytics and the entire AI/ML model lifecycle, while enabling governance and collaboration," said Scott Burke, CTO at Verily Health.
Press releases | Verily | Alphabet Precision Health Company
💧 A Watershed Moment in Public Health Verily Health is a leader in the laboratory science behind wastewater-based epidemiology. In collaboration with scientific organizations, government agencies, and commercial organizations, our scientists conduct research to develop and validate assays needed to consistently and accurately measure the concentration of pathogens in wastewater in near real time — providing information about levels of disease spread within communities. Watch the full episode of A Watershed Moment to learn how this innovation works.
A Watershed Moment
Our Chief Clinical Officer, Vindell Washington, will be keynoting the CU Anschutz Innovation Forum on April 21. This year’s focus, Pathways to Impact, addresses a core challenge that Verily Health is dedicated to solving: how to translate research and innovation into meaningful, scalable outcomes for patients. Hear our perspectives on how we are approaching these challenges, including the crucial role of data and AI in advancing more equitable and effective care, through our partnership with UCHealth, University of Colorado Anschutz, and RefinedScience. 📍 CU Anschutz Medical Campus 🗓️ April 21, 2026
2026 CU Anschutz Innovation Forum Pathways to Impact
The average study activation time is 9.4 months. That’s nearly triple the NCI’s 90-day target. The gap isn’t from a lack of study site effort. It’s due to complexity. In our latest Verily Viewpoint Study Start Up blog, we break down the hidden costs of delayed trial start up at AMCs and IDNs, and outline how these enterprise research sites can bring efficiency-driving structure, visibility, and predictability to activation.
From Delays to Delivery: Faster Study Activation for Sites
We’re pleased to announce that Victor Chen, former Sr. Managing Director, Kaiser Permanente Northern California, has joined us as a strategic advisor. Victor is a seasoned clinical research leader whose deep industry expertise will be instrumental in supporting our provider and research site clients. His expertise will be a major catalyst as we work to accelerate high-impact research and bring cutting-edge treatments to patients sooner. If you’re attending WCG MAGI in a couple of weeks, hear Victor share his insights on the future of clinical operations. We’re proud to have him representing our mission on the big stage.
We’re pleased to announce that Victor Chen, former Sr. Managing Director, Kaiser Permanente Northern California, has joined us as a strategic advisor. Victor is a seasoned clinical research leader whose deep industry expertise will be instrumental in supporting our provider and research site clients. His expertise will be a major catalyst as we work to accelerate high-impact research and bring cutting-edge treatments to patients sooner. If you’re attending WCG MAGI in a couple of weeks, hear Victor share his insights on the future of clinical operations. We’re proud to have him representing our mission on the big stage.
At the Northeast Business Group on Health event last week, Carolyn Bradner Jasik, MD, our Associate Chief Clinical Officer, discussed how employers can help their team members tackle the growing challenge of cardiometabolic disease with precision health approaches. Key insights: ➡️ Who you partner with on AI in healthcare matters: Privacy, infrastructure, and trust aren’t optional. The future of care will be AI-enabled, but only if it’s built responsibly. ➡️ Focus on value: AI should lower the cost of care and deliver savings from efficiency, not just promises of outcomes. ➡️ Look beyond point solutions: Verily Health is building the infrastructure for connected, interoperable care. Medication is only part of the solution; support and adherence are what drive outcomes. We believe AI can meet patients where they are to help with behavior change.
At the Northeast Business Group on Health event last week, Carolyn Bradner Jasik, MD, our Associate Chief Clinical Officer, discussed how employers can help their team members tackle the growing challenge of cardiometabolic disease with precision health approaches. Key insights: ➡️ Who you partner with on AI in healthcare matters: Privacy, infrastructure, and trust aren’t optional. The future of care will be AI-enabled, but only if it’s built responsibly. ➡️ Focus on value: AI should lower the cost of care and deliver savings from efficiency, not just promises of outcomes. ➡️ Look beyond point solutions: Verily Health is building the infrastructure for connected, interoperable care. Medication is only part of the solution; support and adherence are what drive outcomes. We believe AI can meet patients where they are to help with behavior change.